Results 81 to 90 of about 21,234 (200)

Human Polyomavirus JCPyV and Its Role in Progressive Multifocal Leukoencephalopathy and Oncogenesis

Frontiers in Oncology, 2019
The human neurotropic virus JCPyV, a member of the Polyomaviridiae family, is the opportunistic infectious agent of Progressive Multifocal Leukoencephalopathy (PML), a fatal disease seen in severe immunosuppressive conditions and, during the last decade,
L. Del Valle, S. Piña‐Oviedo
semanticscholar   +1 more source

Susceptibility-Weighted MR Imaging Hypointense Rim in Progressive Multifocal Leukoencephalopathy: The End Point of Neuroinflammation and a Potential Outcome Predictor

American Journal of Neuroradiology, 2019
This retrospective study included 18 patients with a definite diagnosis of progressive multifocal leukoencephalopathy. Ten patients were HIV-positive, 3 patients had natalizumab-associated PML, 1 patient had multiple myeloma, 3 patients had a history of ...
M. Thurnher, J. Boban, A. Rieger, E. Gelpí   +3 more
semanticscholar   +1 more source

Multifocal Leukoencephalopathy

Pediatric Neurology Briefs, 1994
A 15-year-old boy with Wiskott-Aldrich syndrome complicated by progressive multifocal leukoencephalopathy (PML) is reported from the University of Miami School of Medicine, FL, and the National Institute of Neurological Disorders and Stroke, Bethesda, MD.
J Gordon Millichap
doaj   +1 more source

Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy

Emerging Infectious Diseases, 2019
Antibodies against PD1 have been used to treat progressive multifocal leukoencephalopathy (PML), a rare brain disease caused by JC virus. We used these antibodies (nivolumab) to treat PML in 3 kidney transplant recipients.
Chloé Médrano, F. Vergez, C. Mengelle, S. Faguer, N. Kamar, A. Del Bello   +5 more
semanticscholar   +1 more source

Sustained Response and Rationale of Programmed Cell Death-1-Targeting for Progressive Multifocal Leukoencephalopathy

Open Forum Infectious Diseases, 2019
In this study, we report a complete (clinical, radiological, and virological) sustained (1 year) response after nivolumab salvage therapy in a progressive multifocal leukoencephalopathy patient.
A. Audemard-Verger, J. Gasnault, M. Faisant, Marie-Catherine Besse, N. Martin-Silva, Mado Berra, L. Fournier, J. Boutémy, G. Maigné, H. de Boysson, A. Ruet, A. Vabret, F. Chapon, G. Martin-Blondel, A. Aouba   +14 more
semanticscholar   +1 more source

Neuroleukemiosis Masquerading as Drug Toxicity in an Adolescent With Refractory AML

American Journal of Hematology, Volume 100, Issue 10, Page 1853-1858, October 2025.
Nia Choi, Deborah Schady, Tim Lotze, Jill Ann Jarrell, Alexandra Rodriguez‐Hernandez, Sandra Aziz, Karen K. Moeller, Joanna S. Yi, Suzanne Woodbury, Andrea N. Marcogliese, Zoann E. Dreyer, Eric S. Schafer   +11 more
wiley   +1 more source

Progressive Multifocal Leukoencephalopathy: Current Insights

Degenerative Neurological and Neuromuscular Disease, 2019
Cases of PML should be evaluated according to predisposing factors, as these subgroups differ by incidence rate, clinical course, and prognosis. The three most significant groups at risk of PML are patients with hematological malignancies mostly ...
Marge Kartau, J. Sipilä, E. Auvinen, M. Palomäki, A. Verkkoniemi-Ahola   +4 more
semanticscholar   +1 more source

Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird’s Eye View

Frontiers in Immunology, 2018
The increased use of newer potent immunomodulatory therapies for multiple sclerosis (MS), including natalizumab, fingolimod, and dimethyl fumarate, has expanded the patient population at risk for developing progressive multifocal leukoencephalopathy (PML)
E. Mills, Y. Mao-Draayer
semanticscholar   +1 more source

Visual consequences of medications for multiple sclerosis: the good, the bad, the ugly, and the unknown

Eye and Brain, 2017
Heather E Moss1,2 1Department of Ophthalmology, Stanford University, Palo Alto, CA, USA; 2Department of Neurology & Neuroscience, Stanford University, Stanford, CA, USA Abstract: Multiple sclerosis (MS) is associated with vision changes both due to ...
Moss HE
doaj  

Immune Reconstitution Inflammatory Syndrome Unmasking or Worsening AIDS-Related Progressive Multifocal Leukoencephalopathy: A Literature Review

Frontiers in Immunology, 2017
Incidence of progressive multifocal leukoencephalopathy (PML) in HIV-infected patients has declined in the combined antiretroviral therapy (cART) era although a growing number of acquired immunodeficiency syndrome (AIDS)-related PML-immune reconstitution
A. Fournier, G. Martin-Blondel, E. Lechapt-Zalcman, J. Dina, A. Kazémi, R. Verdon, E. Mortier, A. de la Blanchardière   +7 more
semanticscholar   +1 more source